Essential Reads: Bright Light Therapy for the Treatment of Depression During Pregnancy, Mixed Findings
In terms of the efficacy of bright light therapy for depression during pregnancy, the jury is still out.
Are Women with PMDD at Increased Risk for Suicidality?
In a recent meta-analysis, Yan and colleagues looked at the prevalence of suicidal ideation among women diagnosed with PMDD.
Weekly Roundup for SEPTEMBER 10, 2021: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance use, and menopausal mental health. For more detailed descriptions of many of these topics, you can sign up to receive our weekly CWMH NEWSLETTER which comes out every Thursday. And don't forget to visit ESSENTIAL READS [...]
Essential Reads: Modafinil and Armodafinil During Pregnancy Associated with Increased Risk of Malformations
Modafinil (brand name Provigil) and armodafinil (Nuvigil) are wake-promoting agents used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea. They are also used in other settings, often in combination with other medications, to treat ADHD symptoms, depressive symptoms, fatigue, and cognitive dysfunction. Danish Study of 50 Modafinil-Exposed Infants In 2020, a Danish study reported a major malformation rate of 12% (n = 6) in [...]
Prospective Data on the Use of Newer Antipsychotics During Pregnancy: No Increase in Risk of Malformations
The most recent publication from the National Pregnancy Registry focuses on overall risk of malformations associated with the class of antipsychotic medications.
NPR’s 1A Live Discusses Perinatal Depression and the New Medication Zuranolone
NPR’s 1A Live hosts an episode focusing on perinatal depression, including information on the new medication zuranolone for the treatment of postpartum depression.